0001144204-19-029513 Sample Contracts

OUTLOOK THERAPEUTICS, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [·], 20__ Debt Securities
Indenture • June 3rd, 2019 • Outlook Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York

Indenture, dated as of [·], 20__, among Outlook Therapeutics, Inc., a Delaware corporation (the “Company”), and [Trustee], as trustee (the “Trustee”):

Sample 1Sample 2Sample 3See All (492)
AutoNDA by SimpleDocs
Outlook Therapeutics, Inc. and _____________, As Warrant Agent Form of Common Stock Warrant Agreement Dated As Of __________
Warrant Agreement • June 3rd, 2019 • Outlook Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York

This Common Stock Warrant Agreement (this “Agreement”), dated as of [●], between Outlook Therapeutics, Inc., a Delaware corporation (the “Company”), and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).

Sample 1Sample 2Sample 3See All (425)
Outlook Therapeutics, Inc. and _____________, As Warrant Agent Form of Debt Securities Warrant Agreement Dated As Of __________
Warrant Agreement • June 3rd, 2019 • Outlook Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York

This Debt Securities Warrant Agreement (this “Agreement”), dated as of [●], between Outlook Therapeutics, Inc., a Delaware corporation (the “Company”), and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).

Sample 1Sample 2Sample 3See All (246)
Outlook Therapeutics, Inc. and _____________, As Warrant Agent Form of Preferred Stock Warrant Agreement Dated As Of __________
Preferred Stock Warrant Agreement • June 3rd, 2019 • Outlook Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York

This Preferred Stock Warrant Agreement (this “Agreement”), dated as of [●], between Outlook Therapeutics, Inc., a Delaware corporation (the “Company”), and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).

Sample 1Sample 2Sample 3See All (200)
Time is Money Join Law Insider Premium to draft better contracts faster.